Location:
2751 Fort Amanda Road Lima, OH 45805
Phone:
567-529-9000
Fax:
567-529-9001
Working Hours:
Monday - Friday: 8.00am - 05.00pm

Patient Portal

Request An Appointment
Request An Appointment

Leuprolide [Lupron, Eligard, Camcevi] – (LHRH Agonist)

  • Home
  • Urologic Cancers
  • Leuprolide [Lupron, Eligard, Camcevi] – (LHRH Agonist)

As a Center of Excellence, Crossroads Urology combines advanced technology with evidence-based protocols to deliver the highest standard of specialized care for our patients.

Call Us when you Need Help!
24/7 Support: +1 567-529-9000
Leuprolide [Lupron, Eligard, Camcevi] – (LHRH Agonist)

Introduction

Leuprolide is a luteinizing hormone-releasing hormone (LHRH) agonist used to treat advanced prostate cancer. Marketed under trade names like Lupron, Eligard, and Camcevi, it suppresses testosterone production, slowing the growth and spread of prostate cancer cells.

Purpose

  • Treats advanced prostate cancer by reducing androgen (testosterone) levels.
  • Used as part of androgen deprivation therapy (ADT) for metastatic and non-metastatic prostate cancer.
  • Offers both short- and long-term testosterone suppression.

How It Works

Leuprolide overstimulates the pituitary gland’s LHRH receptors, initially causing a testosterone surge (flare) before suppressing its production. This results in sustained low testosterone levels, similar to surgical castration.

Usage

  • Administered as an injection, with formulations providing 1-, 3-, 4-, or 6-month durations.
  • Eligard and Camcevi offer additional delivery options with similar efficacy.
  • Periodic monitoring of PSA levels and testosterone levels is recommended.

Considerations

  • Common side effects include hot flashes, fatigue, mood swings, and reduced libido.
  • The initial testosterone surge may cause temporary cancer symptom flare-ups, requiring concurrent anti-androgen therapy to mitigate.
  • Rare side effects include cardiovascular risks and osteoporosis; patients may need bone density monitoring.

At Crossroads Urology

At Crossroads Urology, Leuprolide-based therapies are a cornerstone of androgen deprivation therapy for prostate cancer. Our providers work with each patient to customize treatment plans, monitor for side effects, and ensure effective testosterone suppression.

Conclusion

Leuprolide-based therapies like Lupron, Eligard, and Camcevi provide powerful and reliable testosterone suppression for advanced prostate cancer, improving outcomes and quality of life. Contact Crossroads Urology today to learn more about these treatments and how they can benefit you.